Condition: Hematologic Neoplasm · Hematopoietic Stem Cell Transplantation · Survivorship · Sponsor: Azienda USL Reggio Emilia - IRCCS
This is a feasibility study to implement a Survivorship Care (SC) Plan for patients with hematologic cancer undergoing hematopoietic stem cell transplantation (HSCT). The study evaluates if the intervention is feasible within the Italian national health system, focusing on retention rates, quality of life, unmet needs and caregiver burden
This description comes directly from the study's public registry record.
Barbara Bressi · barbara.bressi@ausl.re.it
Stefania Costi · stefania.costi2@ausl.re.it
Always discuss trial participation with your own doctor first.
| Research and EBP Unit, Azienda USL-IRCCS di Reggio Emilia | Reggio Emilia, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07579065